ALPS Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-38,235
| Closed | -$1.42M | – | 1042 |
|
|
2023
Q1 | $1.42M | Sell |
38,235
-605
| -2% | -$22.5K | 0.01% | 372 |
|
|
2022
Q4 | $1.76M | Buy |
38,840
+8,461
| +28% | +$383K | 0.02% | 318 |
|
|
2022
Q3 | $2.12M | Sell |
30,379
-2,556
| -8% | -$179K | 0.02% | 299 |
|
|
2022
Q2 | $2.21M | Buy |
+32,935
| New | +$2.21M | 0.02% | 304 |
|
|
2020
Q4 | – | Sell |
-56,836
| Closed | -$9.44M | – | 890 |
|
|
2020
Q3 | $9.44M | Sell |
56,836
-2,694
| -5% | -$447K | 0.14% | 136 |
|
|
2020
Q2 | $6.8M | Sell |
59,530
-17,470
| -23% | -$1.99M | 0.09% | 138 |
|
|
2020
Q1 | $5.92M | Sell |
77,000
-2,456
| -3% | -$189K | 0.09% | 134 |
|
|
2019
Q4 | $10.2M | Buy |
79,456
+1,076
| +1% | +$139K | 0.08% | 114 |
|
|
2019
Q3 | $6.11M | Buy |
78,380
+3,177
| +4% | +$248K | 0.05% | 135 |
|
|
2019
Q2 | $7.75M | Sell |
75,203
-7,231
| -9% | -$745K | 0.06% | 130 |
|
|
2019
Q1 | $6.04M | Buy |
82,434
+7,290
| +10% | +$534K | 0.04% | 149 |
|
|
2018
Q4 | $3.19M | Buy |
75,144
+17,881
| +31% | +$759K | 0.02% | 188 |
|
|
2018
Q3 | $2.7M | Buy |
57,263
+15,104
| +36% | +$711K | 0.02% | 216 |
|
|
2018
Q2 | $2.08M | Buy |
+42,159
| New | +$2.08M | 0.01% | 226 |
|